A study conducted by digestive healthcare company Oshi Health in partnership with a national health plan found that virtual multidisciplinary care for gastrointestinal disorders improves patient ...
A team of researchers looked at the national clinical and economic burden of gastrointestinal emergency department visits in the U.S. and found GI illnesses make up a substantial burden, according to ...
A population-based study drew a possible connection between gastrointestinal (GI) symptoms and the multiple sclerosis (MS) prodrome. Patients with multiple sclerosis (MS) endure higher rates of drug ...
A new study suggests acidogenic foods may raise your gastrointestinal cancer risk. Acidogenic foods, like red and processed meats, create acid in your body. Eating more plants has been correlated with ...
71.4% of MetaXplore™ reports from 4,616 patients identified actionable results 41.9% tested positive for abnormal microbiome markers linked to gastrointestinal health 9.9% tested positive for ...
John L. Marshall, MD: Zolbetuximab is a drug that you probably don’t know the name of, but you’re going to soon. Though you may have heard of claudin 18.2. Now, that’s been in the literature for a ...
Comparing outcomes for early and late drainage of malignant ascites. Background: Black individuals, including African Americans, experience a disproportionate cancer burden and exhibit the lowest ...
Developing depression half a month after gastrointestinal (GI) disease presented an elevated risk of dementia among participants in a November study published in Alzheimer’s & Dementia. “These ...
FORT LAUDERDALE, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or “Motus GI” or “the Company”), a medical technology company focused on improving endoscopic outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results